BioSpace News Archive

The report further provides details about each segments and regions covered in the global Cervical Interbody Fusion Cages market. The data has been collected through extensive primary and secondary research and is validated by experts in the industry.

HepaTx announced the Decision to Grant Patent protection by the Japanese Patent Office, further strengthening the Company’s intellectual property position and coverage for the company’s technology.

The data has been collected through extensive primary and secondary research and is validated by experts in the industry.

SAIVE is a 400-participant, multicenter, randomized, double-blind, placebo-controlled study with an independent Data Monitoring Committee, conducted in the European Union.

Adocia, a clinical-stage biopharmaceutical company focused on the discovery and development of therapeutic solutions for the treatment of diabetes and other metabolic diseases, announced the completion of the sale of its laboratory and office complex located in Lyon, France to a specialized investor.

MaaT Pharma announced that the first patient has been dosed in its pivotal Phase 3 trial investigating MaaT013 in patients with acute Graft-versus-Host-Disease with gastrointestinal involvement who are refractory to both steroids, the standard of care first-line treatment, and to ruxolitinib1 used as a second-line treatment.

The industry analysis report is considered a valuable source of information about the global Serotonin Antagonists industry and lays stress on the future market scope, emerging industry trends, industry statistics, and market growth potential during the forecast years.

The global acute hospital care market size is expected to worth around US$ 4.58 Trillion by 2027 and expanding growth at a CAGR 6.5% over the forecast period 2021 to 2027.

According to Vision Research Reports, the in vitro diagnostics market size is expected to be worth around US$ 125.5 billion by 2030 from valued at US$ 85.3 billion in 2020.

According to Precedence Research, the global surgical sutures market size is expected to reach around US$ 6.4 billion by 2030 with a registered CAGR of 5.7% from 2022 to 2030.